# The Use of Teledermatology in the Treatment of Patients With Severe Acne on Isotretinoin

> **NCT03707236** · NA · WITHDRAWN · sponsor: **Massachusetts General Hospital**

## Conditions studied

- Acne Vulgaris

## Interventions

- **BEHAVIORAL:** Teledermatology visits

## Key facts

- **NCT ID:** NCT03707236
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-04-01
- **Primary completion:** 2023-04-01
- **Final completion:** 2023-04-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was planned prior to COVID-19; after pandemic teledermatology use became prevalent making the results of this study no longer necessary/relevant
- **Last updated:** 2023-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03707236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03707236, "The Use of Teledermatology in the Treatment of Patients With Severe Acne on Isotretinoin". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03707236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*